OCD Trial, Recruiting NCT07587112 Sponsor: Taipei Veterans General Hospital, Taiwan Condition: OCD
Back to Ocd

OCD Trial, Recruiting

NCT07587112
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 65 years old.
  • People who have been diagnosed with obsessive-compulsive disorder (OCD) based on standard medical guidelines (DSM-5) — previous treatments do not need to have failed for you to be eligible.
  • People whose OCD symptoms are at least mild to moderate in severity, as measured by a standard OCD assessment tool called the Y-BOCS (a score of 14 or higher).

Who may not be able to join:

  • People who have been diagnosed with schizophrenia, bipolar disorder, a brain-related psychotic disorder, alcohol use disorder, or drug use disorder.
  • People who have been assessed as being at high risk of suicide within the past year.
  • People who currently have a serious or active medical or surgical health condition.
  • People who have had, or are planning to have, brain surgery, or who have any metal implants in their brain or body (such as a brain stimulator or heart pacemaker).
  • People who have abnormal structures in the brain (such as a brain tumour) or neurological conditions (such as epilepsy, stroke, meningitis, or encephalitis).
  • People who are pregnant.
  • People who are unable to tolerate being inside a scanning machine (PET/MRI) due to claustrophobia or severe anxiety in confined spaces.
  • People who, for any reason, may not be able to follow the study requirements — including those unable to cooperate, unable to give informed consent, or deemed ineligible by the research team after an initial screening.
  • People taking certain medications (such as some antidepressants or antipsychotics) that may increase the risk of seizures or suicide.
  • People with a known allergy to a substance called 18F-FDG, which is used in the brain scan.
  • People who have previously had a bad reaction to TMS (a type of brain stimulation) or are allergic to the positioning cap used during TMS.
  • People who have any metal objects within approximately 30 cm of their head (in the area where the stimulation device would be placed).
  • People who have previously received, or are currently receiving, treatment with electroconvulsive therapy (ECT) or vagus nerve stimulation (VNS).

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 886-2-55704055

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Taipei Veterans General Hospital, Taiwan
Registry
ClinicalTrials.gov
Start date
22 September 2025
Est. completion
31 December 2027

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

the percentage changes in Y-BOCS scores after treatments

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov